| | | | | | | | | | | | | | |
| Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds |
(a) Unregistered Sale of Equity Securities
None.
(b) Use of Proceeds
None.
(c) Repurchase of Equity Securities
In November 2022, Adient’s board of directors authorized the repurchase of Adient’s ordinary shares up to an aggregate purchase price of $600 million with no expiration date. Under the share repurchase authorization, Adient’s ordinary shares may be purchased either through discretionary purchases on the open market, by block trades or privately negotiated transactions. The number of ordinary shares repurchased, if any, and the timing of repurchases will depend on a number of factors, including share price, trading volume and general market conditions, as well as on working capital requirements, general business conditions and other factors. Repurchased shares were retired immediately upon repurchase. During the three months ended March 31, 2025, there was no share repurchase activity. As of March 31, 2025, the remaining aggregate amount of authorization remaining under the share repurchase authorization was $235 million.
Adient plc | Form 10-Q | 47
